_gif.gif)
Sirio Europe has announced the launch of LifeChews, a patented, plant-based, chewable "jelly tablet" designed to deliver high payloads of active ingredients. The new format addresses long-standing industry challenges regarding the stability and bioavailability of oil-soluble actives, providing nutraceutical brands with a versatile vehicle for trending health categories.
The launch comes as market data from ITC indicates a significant shift in consumer priorities, with 43% of purchasers seeking greater efficacy and 45% prioritizing pleasant taste when selecting supplement formats.
Advanced Bioavailability and Dispersion Technology
LifeChews utilise a patented technology that ensures the uniform dispersion of 5 μm oil droplets. This particle size is comparable to lipid structures found in human milk, which Sirio credits for the format's optimised absorption.
Clinical studies cited by the company demonstrate significant performance metrics:
Enhanced Absorption: LifeChews achieved a 161% higher blood plasma DHA concentration compared to control groups.
Improved Bioavailability: The format represents a 198% improvement in overall bioavailability for targeted actives.
Stability: Digestion studies confirmed an even distribution of DHA during simulated gastric and intestinal conditions, indicating high stability during the digestive process.
Versatile Application Across Health Categories
The jelly tablet format is specifically engineered for lipid-based nutrients that have traditionally been difficult to formulate in chewable formats due to oxidation, poor dispersibility, and unpleasant aftertastes.
LifeChews are suitable for a wide range of ingredients, including:
Omega-3 oils
Fat-soluble vitamins
Coenzyme Q10
Carotenoids (such as lutein and astaxanthin)
Sirio has already developed four initial concepts utilising the format, targeting brain health, heart health, immunity, and longevity—sectors that currently dominate consumer interest.
Strategic Market Positioning
By combining high-nutrient payloads with a plant-based, chewable delivery system, Sirio aims to help its partner brands differentiate themselves in a crowded marketplace.
"LifeChews are a gamechanger in how consumers experience supplements," said Sara Lesina, General Manager at Sirio Europe. She noted that the combination of clinical validation and high payload capacity allows brands to deliver real added value in high-growth categories.
The introduction of LifeChews provides a functional solution for manufacturers looking to move away from traditional softgels or standard gummies toward more effective, scientifically backed delivery systems.
